Agreement intended to support an orderly market and improve liquidity in Kane Biotech's common shares WINNIPEG, Manitoba, Oct. 21, 2026 (GLOBE NEWSWIRE) -- Kane Biotech Inc. (TSX-V:KNE) (the "Company", "Kane" or "Kane Biotech"), a biotechnology company commercializing and developing technologies and products that address microbial biofilms, today announced that, subject to the approval of the TSX Venture Exchange (the "TSXV"), it has engaged Independent Trading Group (ITG), Inc. ("ITG") to provide market-ma ...